KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash from Investing Activities (2016 - 2025)

Exact Sciences (EXAS) has disclosed Cash from Investing Activities for 16 consecutive years, with $91.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 317.61% to $91.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $195.1 million, a 144.13% increase, with the full-year FY2025 number at $195.1 million, up 144.13% from a year prior.
  • Cash from Investing Activities was $91.1 million for Q4 2025 at Exact Sciences, up from -$86.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $224.9 million in Q2 2025 to a low of -$793.8 million in Q2 2021.
  • A 5-year average of -$60.3 million and a median of -$38.2 million in 2024 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: crashed 12341.49% in 2021, then surged 317.61% in 2025.
  • Exact Sciences' Cash from Investing Activities stood at $78.4 million in 2021, then plummeted by 174.15% to -$58.2 million in 2022, then dropped by 14.8% to -$66.8 million in 2023, then soared by 37.29% to -$41.9 million in 2024, then surged by 317.61% to $91.1 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Cash from Investing Activities are $91.1 million (Q4 2025), -$86.5 million (Q3 2025), and $224.9 million (Q2 2025).